New Market Research reports published this week

New Market Research reports available this week from BCC Research are:

Carbon Nanotubes: Technologies and Global Markets

The primary objective of this report is threefold:

• Assess the current state-of-the-art in Carbon Nanotubes (CNTs) production and technical applications understanding
• Identify the current players seeking to exploit their unique properties
• Evaluate actual or impending markets in terms of the technical readiness of CNTs and the projected market revenues.

For more information on this report and to download the introduction chapter for free, visit http://www.bccresearch.com/report/NAN024D.html

Drug-device Combinations: The Global Market

This report discusses key markets for drug device combination products. It provides descriptions of technologies and products, a review of the status of R&D initiatives and a forecast of the market through 2014. Company profiles and a patent analysis are provided as well. Example product categories that are covered include drug-eluting stents (DES), drug-eluting beads (DEB), antimicrobial catheters, antibiotic-loaded bone cements, glass ionomer cements, bone graft substitutes, antibacterial releasing dental restorative materials, biologic wound care products such as collagen-based dressings as therapeutic agents for wound healing, drug device combination products for ocular applications, photodynamic therapy, and other important niches.

For more information on this report and to download the introduction chapter for free, visit http://www.bccresearch.com/report/PHM045B.html

Antennas for Systems and Devices: Technologies and Global Markets

This report tries to make sense of the exceptionally fragmented antenna market. Prima facie, it would not be wrong to assume that the antenna market should display a level of homogeneity found in the markets of other wireless communication components such as basebands, modems, and radio frequency (RF) front ends. Such an expectation is way off the mark. What dictates the dynamics of antenna markets is the end application. It is not uncommon to notice entire antenna supply chains built closely around the interest of end-application users, rather than being heavily focused on interactions with other value adders in the telecommunications domains.

For this reason, this report considers the end-application sector as the primary classification criterion. To render the maximum level of granularity to the study, the report has identified 10 end-application categories, which are further subdivided into antenna technologies, antenna materials, and geographical regions.

On the whole, BCC Research forecasts that the future of antennas will continue to be driven by that of its end applications. However, commonalities as mentioned above will lead to the adoption of smarter technologies in antenna synthesis and operations. The market is thus likely to witness antennas that are lighter, smaller, power efficient and, most importantly, intelligent.

For more information on this report and to download the introduction chapter for free, visit  http://www.bccresearch.com/report/IFT073A.html

Access over 1000 Market Research Reports with BCC Research's Report Subscription Services

For companies and institutions that need regular access to market research, analysis and forecasts, the Reports Subscription Services from BCC is an ideal option. Each subscription package is customized to your organization's budget and business intelligence needs.

Visit http://www.bccresearch.com/subscribe_report.php for more information. 

Call our Sales team at 866-285-7215 or e-mail reportsubs@bccresearch.com to discuss a Custom Report Subscription Package

Global Market for Alzheimer’s Disease Therapeutics and Diagnostics to be worth $9.6 Billion In 2014

According to a new technical market research report, ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS: GLOBAL MARKETS (PHM062A) from BCC Research (www.bccresearch.com), the value of the Alzheimer’s disease market is an estimated $8 billion in 2009, but is expected to increase to $9.6 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 3.7%.

The largest segment of the market, disease-modifying therapeutics, is projected to decrease at a CAGR of -2.6%, dropping to $5.2 billion in 2014, after being valued at nearly $6 billion in 2009.

Diagnostics/biomarkers, the second-largest segment of the market, is estimated at $1.2 billion in 2009, and is expected to increase at a 5-year CAGR of 19.6% to reach nearly $2.9 billion in 2014.

The therapeutics for treatment of symptoms segment is expected to have a 5-year CAGR of 5.1%, with values of $567 million in 2009 and $726 million in 2014.

The smallest segment of the market, imaging products, is projected to have a healthy 5-year CAGR of 18.7%, rising from $361 million in 2009 to $852 million in 2014.

Alzheimer’s disease is becoming an increasingly difficult challenge to caregivers, families and the healthcare industry as the number of patients increases and the frustration with a lack of effective treatments grows. Though many marketed drugs have been approved for AD, this remains a significant area of unmet medical need. Clinical success has proven elusive; however, numerous companies are developing novel treatments.

BCC’s key objective was to present a comprehensive analysis of the current pipeline of therapeutic and diagnostic technologies, analyze the market, and outline key factors that will influence the therapeutic area in the next few years.

The intended audience for this report is the pharmaceutical and biotechnology industries and diagnostics, as well as the medical industry that treats patients in these areas.

The US Pet Industry: Food, Accessories, Health Products and Services

According to a new technical market research report, THE PET INDUSTRY: FOOD, ACCESSORIES, HEALTH PRODUCTS AND SERVICES (FOD007J) from BCC Research (www.bccresearch.com), the U.S. market for the pet care industry and products was valued at an estimated $46 billion in 2009, and is expected to increase to $56.5 billion by the end of 2014, for a compound annual growth rate (CAGR) of 4.2%.

The pet food segment has the largest share of the market at $19.1 billion in 2009, and is expected to increase by 2014 to more than $23 billion, for a CAGR of 3.8%.

Veterinary care was the second-largest segment at $12.2 billion in 2009, and is expected to rise to $14.6 billion in 2014, for a CAGR of 3.7%.

The segment with the greatest projected 5-year rise in value is the Other Pet Supplies segment (including over-the-counter medicines), which is expected to grow from $11.3 billion in 2009 to $15.3 billion in 2014, for a CAGR of 6.4%.

The pet industry is a major segment of the U.S. economy. In 2008, American pet owners spent more than $43 billion on their small companions. Since BCC published its last report on the pet industry in 2006, continued growth in all segments of the pet industry has provided an opportunity for both existing players and new entrants.

This report analyzes developments in all animal segments, including bird, fish, small mammal, and reptile products. Sections of the report include: Pets and Their Owners, Pet Industry Overview, Pet Food Segment, Pet Services Segment, Pet Supplies Segment, and International Aspects.

Due to the increasing importance of international markets for U.S. manufacturers and retailers, the report includes an analysis of global trends, with an overview of key export markets for U.S. pet products.

The report is intended for executives and consultants in the pet food, pet supplies, veterinary, and other pet services segments of the industry. It will also be of interest to financial analysts, venture capitalists, and investors.

RSS Feeds – Food and beverage

Source: BCC Research

Report on the Global Markets for Industrial and Utility Solar Thermal Technologies released

BCC’s goal in conducting this study was to assess and describe the current status and assess the potential growth of the worldwide solar thermal (ST) industry for all major industrial and utility scale ST technologies.

More specifically, the study included the following objectives:

1. Summarize existing industrial and utility scale ST technologies and promising emerging technologies that are under development.

2. Evaluate the existing ST industry, focused on the manufacturers and providers of major components for viable industrial or utility scale ST technologies.

3. Assess market potential for industrial and utility scale ST technologies over a 5-year period, from 2009 through 2014.

Visit http://www.bccresearch.com/report/EGY070A.html to download the Introduction chapter for free and to get more information on this report.

Global Market for Friction Products and Materials worth More Than $15 Billion By 2014

According to a technical market research report, The Friction Products and Materials Market (AVM028D) from BCC Research (http://www.bccresearch.com/), the global friction products business is expected to reach $15.7 billion by 2014. Its 5-year compound annual growth rate (CAGR) from 2009 to 2014 is projected to be 8%.

The friction materials and products industry represents a $10.7 billion global business. This BCC study finds that, while the global recession has exacerbated the difficulties facing the business, including increased competition in North America and Western Europe due to overcapacity, mature demand, and other factors, during the next 5 years, cyclical recovery will figure prominently in the environment for friction materials.

Beyond the cyclical rebound, the mature ground transportation segment will feature slow growth in the long term. This is especially the case in developed nations, but in emerging markets, light-vehicle applications offer opportunities. A recovery of global air transportation in the long term heralds an improved outlook for friction products in this segment. Increased defense spending also may play a role.

Other applications present a mixed picture. Increasing global income and the rise of middle classes in developing nations offers opportunities for friction materials in appliances. An eventual recovery of capital spending in combination with rapid industrialization also will provide business opportunities for friction materials in industrial machinery. Oil well, construction machinery, railway, and other industrial applications will offer more modest opportunities.

Among the report’s findings are the following:

• The ground transportation segment of the friction products and materials market was worth more than $5.8 billion in 2008. That was expected to decline slightly to $5.5 billion in 2009, but rise to 8.1 billion in 2014, for a 5- year CAGR of 8%.
• The aircraft/aerospace market is the smallest of the segments, but is expected to rise slightly from 2008 to 2009, $938 million to $941 million, and increase at a CAGR of 7.7% to reach nearly $1.4 billion in 2014.
• The industrial segment, combined with other smaller segments, amounted to nearly $4.7 billion in 2008, but is expected to decline to less than $4.3 billion in 2009. A rebound is projected for 2014, however, to nearly $6.3 billion, for a CAGR of 8%.

Global Biochips Market: Microarrays and Lab-On-A-Chip to Be Worth $6 Billion In 2014

According to a new technical market research report from BCC Research (www.bccresearch.com), the global market value for biochip products is an estimated $2.6 billion in 2009, but is expected to increase to nearly $6 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 17.7%.

The largest segment in the market, DNA microarrays, is expected to increase at a 5-year CAGR of 15.2%, from $1.3 billion in 2009 to $2.7 billion in 2014.

The second-largest segment, lab-on-a-chip products, is expected to reach $2.1 billion in 2014. The market in 2009 is estimated to be $817.6 million. Thus, the 5-year CAGR is projected to be a healthy 20.9%.

The third-largest segment, protein microarrays, is expected to increase in value from an estimated $343 million in 2009 to $848 million in 2014, for a 5-year CAGR of 19.8%.

The smallest segment of the biochips market, emerging microarrays, is expected to have the slowest growth rate. It’s projected CAGR is 15.1%, increasing in value from an estimated $131 million in 2009 to nearly $265 million in 2014.

Biochips currently are undergoing an important transition from primarily research-and-development tools to applied applications in next-generation sequencing, drug discovery and development, and clinical diagnostics. This shift toward clinical and applied markets is driven by large-scale efforts to associate genetic variation with disease susceptibility and progression. At the same time, miniaturization and integration of biochip devices is occurring. These factors drive down biochip costs, increase their portability, and validate their use as clinical diagnostics.

This report’s scope includes the major biochip technologies that are likely to become commercialized within 5 years. Influencing factors, including large-scale integration, microfluidics, nanotechnology, large-scale biochip, genomic and proteomic research initiatives, cancer diagnostic and treatment trends, and drug discovery and development needs, are discussed.

This study will be of particular interest to the companies in the following industries: diagnostics, pharmaceuticals, biotechnology, nanotechnology, life-sciences tools, biodefense, medical devices, polymers, glass, bioinformatics, and genetic services. It will also be of interest to companies involved in drug and/or biomarker discovery programs, manufacturers of microarrays and lab-on-a-chip devices, antibodies, restriction enzymes or primers, bioinformatics developers, and cancer researchers and clinicians.

RSS Feeds – Biotechnology

Global Market for Equipment Used In Biotechnology Applications to Be Worth $7.3 Billion In 2014

According to a new technical market research report, GLOBAL MARKET FOR EQUIPMENT USED IN BIOTECHNOLOGY APPLICATIONS (BIO070A) from BCC Research (www.bccresearch.com), the global market value for biotechnology equipment is an estimated $5.5 billion in 2009, but is expected to increase to nearly $7.3 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 5.8%.

The largest segment of the market, imaging, is expected to increase at a 5-year CAGR of 4.9%, from $1.7 billion in 2009 to $2.1 billion in 2014.

The second-largest segment, electrophoresis, is expected to reach a value of $1.2 billion in 2014. The market in 2009 is estimated at more than $966 million. Thus, the 5-year CAGR is projected to be 4.9%.

The segment projected to see the largest growth from 2009 to 2014 is array. It is expected to increase from an estimated $326 million in 2009 to more than $504 million in 2014, for a 5-year CAGR of 9.1%.

The biotechnology equipment market includes the instruments used in separation, purification, and analysis of biomolecules in drug discovery and diagnostics. The market growth of biotechnology instruments has been driven by the growth in drug discovery research, which itself follows the increased demand for newer drugs and therapies worldwide. Moreover, the end of the human genome project has marked revolutions in genomics and proteomics, thus enhancing global research on genes, proteins, and related biomolecules.

The technology market includes chromatography, electrophoresis, sequencers and synthesizers, laboratory automation, an array market, immunoassay, imaging, and mass spectrometry. The end-user market examined in this report includes biopharmaceuticals, academic institutions, government, agriculture, food and beverages, environmental testing labs, gene/protein expression, toxicogenomics, toxicoproteomics, pharmacogenomics, pharmacoproteomics, HTS screening, life science and clinical imaging.

The intended audience for the report would be professionals in pharmaceutical and biotechnology companies, analytical instrument manufacturers, distributors and suppliers, pharmaceutical and biotechnology associations, and contract research organizations.